Can you provide the last earnings date for KALVISTA PHARMACEUTICALS INC?
KALVISTA PHARMACEUTICALS INC (KALV) last reported earnings on 3/25/2026.
KALVISTA PHARMACEUTICALS INC (KALV) Earnings History & Surprises
NASDAQ:KALV • US4834971032
Current stock price
19.9 USD
+0.13 (+0.66%)
At close:
19.7 USD
-0.2 (-1.01%)
After Hours:
KALV Earnings overview
Past quarterly earnings results for KALVISTA PHARMACEUTICALS INC (KALV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q3 / 2026
- EPS Estimate
- -$0.32
- Revenue Estimate
- 56.732M
Last Reported
Most Recent- Release Date
- Mar 25, 2026
- Period
- Q2 / 2026
- EPS Reported
- -$0.92
- EPS Surprise
- -175.71%
- Revenue Surprise
- -71.76%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | -0.92 | -0.33 | -175.71% | -1.10% | 13.692M | 48.481M | -71.76% | - |
| Q1 2026 | -1.12 | -0.45 | -150.37% | -28.74% | 1.426M | 39.963M | -96.43% | - |
| Q4 2025 | 0.92 | -0.48 | 291.25% | 189.89% | 35.386M | - | - | |
| Q3 2025 | -0.78 | -0.89 | 12.51% | 7.14% | 13.692M | - | - | |
| Q2 2025 | -0.91 | -0.93 | 1.74% | -13.75% | 1.426M | - | - | |
| Q1 2025 | -0.87 | -0.93 | 6.68% | -17.57% | - | - | ||
| Q4 2024 | -1.02 | -0.75 | -36.67% | -32.47% | - | - | ||
| Q3 2024 | -0.84 | -0.78 | -7.35% | -12.00% | - | - | ||
| Q2 2024 | -0.80 | -0.80 | 0.27% | 11.11% | - | - | ||
| Q1 2024 | -0.74 | -0.88 | 15.48% | 21.28% | - | - | ||
| Q4 2023 | -0.77 | -0.96 | 19.55% | 21.43% | - | - | ||
| Q3 2023 | -0.75 | -1.00 | 25.35% | 18.48% | - | - | ||
| Q2 2023 | -0.90 | -1.08 | 16.51% | -12.50% | - | - | ||
| Q1 2023 | -0.94 | -1.06 | 11.41% | -42.42% | - | - | ||
| Q4 2022 | -0.98 | -1.11 | 11.58% | -50.77% | - | - | ||
| Q3 2022 | -0.92 | -0.94 | 2.57% | -64.29% | - | - | ||
| Q2 2022 | -0.80 | -0.81 | 0.90% | -37.93% | - | - | ||
| Q1 2022 | -0.66 | -0.73 | 9.18% | -8.20% | - | - | ||
| Q4 2021 | -0.65 | -0.57 | -13.77% | -75.68% | 594.997K | -100.00% | -100.00% | |
| Q3 2021 | -0.56 | -0.62 | 9.75% | -7.69% | 874.283K | -100.00% | - | |
| Q2 2021 | -0.58 | -0.68 | 15.29% | -75.76% | 425.003K | -100.00% | - | |
| Q1 2021 | -0.61 | -0.61 | -0.01% | -45.24% | 1.224M | -100.00% | -100.00% | |
| Q4 2020 | -0.37 | -0.67 | 44.39% | - | 3.82M | 1.692M | 125.77% | - |
| Q3 2020 | -0.52 | -0.27 | -95.01% | - | 11.652M | -100.00% | - | |
| Q2 2020 | -0.33 | -0.56 | 41.18% | - | 3.324M | -100.00% | - | |
| Q1 2020 | -0.42 | -0.63 | 33.59% | - | 1.58M | 3.283M | -51.87% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-5.58%
Max EPS beat (4)
291.25%
Min EPS beat (4)
-175.71%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, KALV has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, KALV reported -5.6% below the EPS estimates on average.
Related analysis
KALVISTA PHARMACEUTICALS INC / KALV Earnings FAQ
Did KALV stock beat earnings estimates in the most recent quarter?
KALVISTA PHARMACEUTICALS INC (KALV) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often KALVISTA PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, KALVISTA PHARMACEUTICALS INC (KALV) has beaten EPS estimates in 2 out of 4 releases.